Financial
FY2025 revenue €3.48bn (+3.3%); operating margin 6.7%; net income €140.4m.
Balance sheet figures not captured from release.
Dräger
HQ Germany · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Fair
Customer rating
No reviews yet
Financial health
Band: FairListed: DRW3.DE
FY2025 revenue €3.48bn (+3.3%); operating margin 6.7%; net income €140.4m.
Balance sheet figures not captured from release.
Source: official results release · Year ended 2025-12-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2025 | €3.5bn | +3.3% | €233.4m | €140.4m | Drägerwerk |
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
Mar 2026: Dräger said it is cutting a low three-digit number of safety-technology jobs at Lübeck by 2028, moving some production to the Czech Republic, and has closed several German sales sites; it said cuts will come through attrition.
Cyber & information governance
No data breaches, cyber incidents or regulator action involving Dräger found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Regulatory & clinical safety
Jan 2026: Dräger recalled certain Vapor 2000 and Vapor 3000 anaesthetic vaporisers after metal residue from a supplier's soldering was found inside, posing potential airway and lung risks; no injuries were reported in the notice.
Contract performance
No notable go-lives, troubled implementations, terminations or customer disputes involving Dräger found in HSH's search of the last 24 months.
Competitors
No competitors linked yet.